Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, High grade lymphoma, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 1/2
This trial is for people with diffuse large B cell lymphoma or follicular lymphoma that has come back after or continued to get worse during treatment.
The trial is now only open to people with follicular lymphoma. There are enough people with diffuse large B cell lymphoma taking part in the trial.
Recruitment start: 1 January 2013
Recruitment end: 10 June 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Johnson
Epizyme, Inc.
Experimental Cancer Medicines Centres (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 12 Jun 2019
CRUK internal database number: 13512